Protection of Fecal Microbiota Transplantation in a Mouse Model of Multiple Sclerosis

• Egile Nagusiak: Kanglan Li (Egilea), Shouchao Wei (Egilea), Li Hu (Egilea), Xiaojian Yin (Egilea), Yingren Mai (Egilea), Chunmei Jiang (Egilea), Xiaoping Peng (Egilea), Xingxing Cao (Egilea), Zhongkai Huang (Egilea), Haihong Zhou (Egilea), Guoda Ma (Egilea), Zhou Liu (Egilea), Huiliang Li (Egilea), Bin Zhao (Egilea)
• Formatua: Liburua
• Argitaratua: Hindawi Limited, 2020-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Given the growing evidence of a link between gut microbiota (GM) dysbiosis and multiple sclerosis (MS), fecal microbiota transplantation (FMT), aimed at rebuilding GM, has been proposed as a new therapeutic approach to MS treatment. To evaluate the viability of FMT for MS treatment and its impact on...